Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CEPI REX Crypto Equity Premium Income ETF	$38.79 -1.4%	$37.44	$31.35 ▼ $52.16	$35.69M	N/A	22,660 shs	26,197 shs
GNOM Global X Genomics & Biotechnology ETF	$7.70 -0.1%	$7.87	$6.80 ▼ $11.88	$46.66M	1.2	63,563 shs	26,099 shs
SETM Sprott Critical Materials ETF	$15.21 +4.9%	$14.14	$11.48 ▼ $20.04	$38.19M	1.81	17,312 shs	39,149 shs
TEKY Lazard Next Gen Technologies ETF	$31.32 -0.4%	$0.00	$24.68 ▼ $32.29	$37.58M	N/A	1,658 shs	1,701 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CEPI REX Crypto Equity Premium Income ETF	0.00%	-1.67%	+3.14%	-16.24%	+3,878,999,900.00%
GNOM Global X Genomics & Biotechnology ETF	0.00%	-0.39%	-5.98%	-21.67%	-28.90%
SETM Sprott Critical Materials ETF	0.00%	+4.07%	+5.00%	-0.30%	-22.81%
TEKY Lazard Next Gen Technologies ETF	0.00%	-1.57%	+11.14%	+3,131,999,900.00%	+3,131,999,900.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CEPI REX Crypto Equity Premium Income ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GNOM Global X Genomics & Biotechnology ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SETM Sprott Critical Materials ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TEKY Lazard Next Gen Technologies ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CEPI REX Crypto Equity Premium Income ETF	2.77	Moderate Buy	$38.79	N/A
GNOM Global X Genomics & Biotechnology ETF	2.69	Moderate Buy	$7.70	N/A
SETM Sprott Critical Materials ETF	2.71	Moderate Buy	$15.21	N/A
TEKY Lazard Next Gen Technologies ETF	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CEPI REX Crypto Equity Premium Income ETF	N/A	N/A	N/A	N/A	N/A	N/A
GNOM Global X Genomics & Biotechnology ETF	N/A	N/A	N/A	N/A	N/A	N/A
SETM Sprott Critical Materials ETF	N/A	N/A	N/A	N/A	N/A	N/A
TEKY Lazard Next Gen Technologies ETF	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CEPI REX Crypto Equity Premium Income ETF	N/A	N/A	30.30	∞	N/A	N/A	N/A	N/A	N/A
GNOM Global X Genomics & Biotechnology ETF	N/A	-$2.34	N/A	∞	N/A	N/A	N/A	N/A	N/A
SETM Sprott Critical Materials ETF	N/A	N/A	24.56	∞	N/A	N/A	N/A	N/A	N/A
TEKY Lazard Next Gen Technologies ETF	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CEPI REX Crypto Equity Premium Income ETF	$6.06	15.62%	N/A	N/A	N/A
GNOM Global X Genomics & Biotechnology ETF	N/A	0.00%	N/A	N/A	N/A
SETM Sprott Critical Materials ETF	$0.31	2.04%	N/A	N/A	N/A
TEKY Lazard Next Gen Technologies ETF	N/A	N/A	N/A	N/A	N/A

Latest TEKY, CEPI, SETM, and GNOM Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/28/2025	CEPI REX Crypto Equity Premium Income ETF	Monthly	$1.3286	43.23%	4/29/2025	4/29/2025	4/30/2025
3/24/2025	CEPI REX Crypto Equity Premium Income ETF	Monthly	$1.4592	43.63%	3/25/2025	3/25/2025	3/26/2025

(Data available from 1/1/2013 forward)

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CEPI REX Crypto Equity Premium Income ETF	N/A
GNOM Global X Genomics & Biotechnology ETF	56.95%
SETM Sprott Critical Materials ETF	N/A
TEKY Lazard Next Gen Technologies ETF	N/A

Insider Ownership

Company	Insider Ownership
CEPI REX Crypto Equity Premium Income ETF	N/A
GNOM Global X Genomics & Biotechnology ETF	5.89%
SETM Sprott Critical Materials ETF	N/A
TEKY Lazard Next Gen Technologies ETF	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CEPI REX Crypto Equity Premium Income ETF	N/A	920,000	N/A	N/A
GNOM Global X Genomics & Biotechnology ETF	N/A	5.28 million	N/A	Optionable
SETM Sprott Critical Materials ETF	N/A	2.51 million	N/A	Not Optionable
TEKY Lazard Next Gen Technologies ETF	N/A	1.20 million	N/A	N/A

TEKY, CEPI, SETM, and GNOM Headlines

Recent News About These Companies

Lazard Converts Mutual Fund to International Equity ETF

May 12, 2025 | etftrends.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TEKY, CEPI, SETM, and GNOM Company Descriptions

REX Crypto Equity Premium Income ETF NASDAQ:CEPI

$38.79 -0.56 (-1.42%)

As of 05/23/2025 04:00 PM Eastern

The REX Crypto Equity Premium Income ETF (CEPI) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is actively managed, investing in crypto-related and digital payment solutions stocks selected from the index. The fund seeks to generate income by writing covered call options on its holdings, aiming for capital growth and current income, while maintaining the flexibility to adapt based on market conditions. CEPI was launched on Dec 4, 2024 and is issued by REX Shares.

Global X Genomics & Biotechnology ETF NASDAQ:GNOM

$7.70 -0.01 (-0.13%)

Closing price 05/23/2025 03:56 PM Eastern

Extended Trading

$7.69 -0.01 (-0.13%)

As of 05/23/2025 04:09 PM Eastern

Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.

Sprott Critical Materials ETF NASDAQ:SETM

$15.21 +0.70 (+4.85%)

Closing price 05/23/2025 03:57 PM Eastern

Extended Trading

$15.22 +0.01 (+0.04%)

As of 05/23/2025 05:39 PM Eastern

The Sprott Energy Transition Materials ETF (SETM) is an exchange-traded fund that mostly invests in materials equity. The fund supports the global move to cleaner energy by tracking an index of US and foreign companies related to energy transition materials. Securities are selected based on revenue and weighted by market-cap. SETM was launched on Feb 1, 2023 and is managed by Sprott.

Lazard Next Gen Technologies ETF NASDAQ:TEKY

$31.32 -0.13 (-0.41%)

As of 05/23/2025 03:43 PM Eastern

The Lazard Next Gen Technologies ETF (TEKY) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund seeks long-term capital appreciation by actively managing a narrow portfolio of global companies involved in the developing or enabling of AI next-generation technologies. TEKY was launched on Apr 4, 2025 and is issued by Lazard.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time